tiprankstipranks
Trending News
More News >
Calidi Biotherapeutics (CLDI)
:CLDI
US Market

Calidi Biotherapeutics (CLDI) Ownership - Who Owns Calidi Biotherapeutics?

Compare
224 Followers

Calidi Biotherapeutics (CLDI) Ownership Overview

3.44%0.64%11.25%1.05%83.62%
11.25% Other Institutional Investors
1.05% ETFs
83.62% Public Companies and Individual Investors
The ownership structure of Calidi Biotherapeutics (CLDI) stock is a mix of institutional, retail, and individual investors. Approximately 12.94% of the company’s stock is owned by Institutional Investors, 3.44% is owned by Insiders, and 83.62% is owned by Public Companies and Individual Investors.
The ownership structure of Calidi Biotherapeutics (CLDI) stock is a mix of institutional, retail, and individual investors. Approximately 11.89% of the company’s stock is owned by Institutional Investors, 3.44% is owned by Insiders, and 1.05% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
992,094Insider2.95%411,719
353,380Institution1.05%146,653
143,131Institution0.43%59,399
94,697Institution0.28%39,299
67,774Insider0.20%28,126
66,712Insider0.20%27,685
61,374Institution0.18%25,470
28,976Insider0.09%12,025
12,501Institution0.04%5,188
10,000Institution0.03%4,150

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
143,131Institution0.43%59,399
61,374Institution0.18%25,470
10,000Institution0.03%4,150

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
353,380Institution1.05%170,506

FAQ

Who Owns Calidi Biotherapeutics (CLDI)?
According to the latest TipRanks data, approximately 11.25% of the company's stock is held by institutional investors, 3.44% is held by insiders, and 83.62% is held by retail investors.
    What percentage of Calidi Biotherapeutics (CLDI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 11.25% of Calidi Biotherapeutics (CLDI) stock is held by institutional investors.
      What percentage of Calidi Biotherapeutics (CLDI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 83.62% of Calidi Biotherapeutics (CLDI) stock is held by retail investors.
        Who owns the most shares of Calidi Biotherapeutics (CLDI)?
        James Schoeneck owns the most shares of Calidi Biotherapeutics (CLDI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis